α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation.
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation.
复制标题
DOI:
10.1161/atvbaha.110.219543
复制
发表时间:
2011-03
期刊:
影响因子:
--
通讯作者:
Schulz E
中科院分区:
文献类型:
--
作者:
Schuhmacher S;Foretz M;Knorr M;Jansen T;Hortmann M;Wenzel P;Oelze M;Kleschyov AL;Daiber A;Keaney JF Jr;Wegener G;Lackner K;Münzel T;Viollet B;Schulz E
Besides its well described metabolic effects, vascular AMP-activated protein kinase (AMPK) can activate endothelial NO synthase, promotes angiogenesis and limits endothelial cell apoptosis. The current study was designed to study the effects of α1AMPK deletion during vascular disease in vivo. Chronic ATII infusion at low subpressor doses caused a mild endothelial dysfunction that was significantly aggravated in α1AMPK knockout mice. Unexpectedly, this endothelial dysfunction was not associated with decreased NO-content, since NO-levels measured by serum nitrite or electron paramagnetic resonance were even increased. However, due to parallel superoxide production, NO was consumed under production of peroxynitrite in ATII-treated α1AMPK knockout mice, associated with NADPH oxidase activation and Nox2 upregulation. As Nox2 is also a component of phagocyte NADPH oxidases, we found a vascular upregulation of several pro-inflammatory markers including inducible NO synthase, vascular cell adhesion molecule-1 and cyclooxygenase-2. Co-treatment with the NADPH oxidase inhibitor apocynin was able to prevent vascular inflammation and also partially restored endothelial function in α1AMPK knockout mice. Our data indicate that in vivo α1AMPK deletion leads to Nox2 upregulation, resulting in endothelial dysfunction and vascular inflammation. This implicates basal AMPK activity as a protective, redox regulating element in vascular homeostasis.